HIGHLIGHTS
- who: Kevin Y. Wu and colleagues from the Division of Ophthalmology, Department of Surgery, University of Sherbrooke, Sherbrooke, QC J G , Canada have published the paper: Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development, in the Journal: Pharmaceutics 2023, 15, 685. of 23/01/2023
- what: The authors will review the most studied gene (i.e., RHO), as well as the new advances regarding other molecular targets.
- how: The results showed that vitamin A alone may slow the decline of ERG amplitude but did not show a significant difference in visual field area . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.